Our Financial Strategy for Creating Life-changing Value
Growth | September 9, 2021
Changes in society caused by COVID-19 and the impact on Kyowa Kirin
Growth | August 19, 2021
Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break
Sustainability | July 27, 2021
AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS
News Release | June 1, 2021
MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting
News Release | May 20, 2021
White Paper on the unrecognized burden of XLH in adults in Europe
Patients | July 13, 2020
